Two common ways you might misinterpret medical research

Posted on by Kurt Jensen

Sophisticated statistics in medical research can be hard to translate to layman's terms, and when they are, these common misinterpretations can be downright misleading.

1. Odds ratios don't express relative risk.

In 1999, media reports resulting from a study published in the New England Journal of Medicine wrongly suggested that black patients and women were 40 percent less likely than white patients and men, respectively, to undergo cardiac catheterization.

The study's authors had used odds ratios to describe the significance of their findings—a common practice among statistically sophisticated researchers—which showed that black patients and women were definitely less likely to be referred for invasive procedures than white patients and men, but not how much less likely.

Continue reading Two common ways you might misinterpret medical research

A revolution in chronic heart failure management and more in CV Directions Vol. 3, No. 1

Posted on by Kurt Jensen

This is the first and only FDA-approved heart failure monitoring solution proven to reduce heart failure hospital admissions when used by physicians to manage heart failure. And the reduction is significant— 28 percent within the first six months and 37 percent over 15 months demonstrated in a large randomized study...

Learn more about CardioMEMS, find strategies to improve case mix index, or build a learning community in your team through preceptorship—all inside the Alliance of Cardiovascular Professionals flagship, peer-reviewed publication, CV Directions.

Continue reading A revolution in chronic heart failure management and more in CV Directions Vol. 3, No. 1

Future of cardiology: personalized care through genetics?

Posted on by Kurt Jensen

Genetic arrhythmia programs are paving new roads for personalized cardiac care—from preventing unnecessary cautionary testing or treatment to improving screening.

Melvin Scheinman, MD—the first person to perform catheter ablation for arrhythmia in a human patient, now chief of the Comprehensive Genetic Arrhythmia Program at the University of California, San Francisco—believes genetic testing will lead to the "ultimate form of personalized medicine," writes Gregory A. Freeman of HealthLeaders Magazine.

"If you examine the genetic background of a patient, you may be able to identify sensitivity to specific drugs, propensity for developing some very serious heart disorders, and at the same time rule out those same things for other people," said Scheinman to HealthLeaders.

"That is really what personalized medicine is all about—delivering the right care to the patient because you truly understand the patient and don't have to treat him or her as just a member of a group with certain statistical risks."

A proliferation of genetic arrhythmia programs "across the country" have been introducing new, measured responses to a sudden cardiac death in the family—preventive healthcare for some, but not all family members.

Continue reading Future of cardiology: personalized care through genetics?

Has ACVP solved a critical issue facing European medical conferences?

Posted on by Sean McElgunn

Thanks to the recent adoption of a new code of ethical conduct by MedTech Europe, a group of industry associations doing business in Europe, the future of European cardiology conferences may soon be in jeopardy.

The reason? More barriers to attendance.

It’s not that these conferences suffer from a lack of interested medical professionals. It’s just that, while many MDs would very much like to attend, registering for a cardiology conference in Europe is not cheap—on the order of thousands of dollars per event.

Everybody, the attendees, the presenters, with the exception of a very limited number of senior professors, has to pay, and it is understood that the physicians will attend more than a few over the course of a year.

And, in the time honored tradition of using off-site attractions as a lure for good registration numbers, the meetings are held in “not cheap” locations across the Continent, further ballooning the cost of attendance.

Continue reading Has ACVP solved a critical issue facing European medical conferences?